SL Science Holding Limited Reports First Half 2026 Financial Results

10/28/2026
Impact: 65
Healthcare

SL Science Holding reported first-half 2026 revenue of $1.39 million, up 23% year over year, and gross profit of about $0.56 million, up 43.3%; gross margin expanded to 40.2% from 34.5%. The company attributed the margin improvement to shifting from direct retail to B2B wholesale distribution in Taiwan and securing better procurement terms. Its net loss widened to $2.16 million from $1.60 million as research and development spending increased 72%. Cash and cash equivalents totaled about $8.31 million at June 30, supported by $7.8 million in PIPE financing tied to its June 2026 Nasdaq listing.

AI summary, not financial advice

Share: